1. Kathman, Stefan G, Koo, Seong Joo, Lindsey, Garrett L, Ghosh, Brahma, Cravatt, Benjamin F. 2023. Remodeling oncogenic transcriptomes by small molecules targeting NONO. In Nature chemical biology, 19, 825-836. doi:10.1038/s41589-023-01270-0. https://pubmed.ncbi.nlm.nih.gov/36864190/
2. Wang, Xu, Han, Mingzhi, Wang, Shuai, Li, Xingang, Wang, Jian. 2022. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention. In Theranostics, 12, 5451-5469. doi:10.7150/thno.72248. https://pubmed.ncbi.nlm.nih.gov/35910786/
3. Lu, Yue, Meng, Linlin, Ren, Ruiqing, Zhang, Yun, Zhang, Cheng. 2024. Paraspeckle protein NONO attenuates vascular calcification by inhibiting bone morphogenetic protein 2 transcription. In Kidney international, 105, 1221-1238. doi:10.1016/j.kint.2024.01.039. https://pubmed.ncbi.nlm.nih.gov/38417578/
4. Li, Hongjun, Jiao, Wanju, Song, Jiyu, Tong, Qiangsong, Zheng, Liduan. 2023. circ-hnRNPU inhibits NONO-mediated c-Myc transactivation and mRNA stabilization essential for glycosylation and cancer progression. In Journal of experimental & clinical cancer research : CR, 42, 313. doi:10.1186/s13046-023-02898-5. https://pubmed.ncbi.nlm.nih.gov/37993881/
5. Roessler, Franziska, Beck, Anita E, Susie, Ball, Popp, Bernt, Strehlow, Vincent. 2022. Genetic and phenotypic spectrum in the NONO-associated syndromic disorder. In American journal of medical genetics. Part A, 191, 469-478. doi:10.1002/ajmg.a.63044. https://pubmed.ncbi.nlm.nih.gov/36426740/